Vulnerability Description
Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.
CVSS Score
6.7
MEDIUM
CVSS:3.1/AV:L/AC:L/PR:H/UI:N/S:U/C:H/I:H/A:H
Affected Products
| Vendor | Product | Versions |
|---|---|---|
| Intel | Battery Life Diagnostic Tool | < 2.2.1 |
Related Weaknesses (CWE)
References
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.Vendor Advisory
- https://www.intel.com/content/www/us/en/security-center/advisory/intel-sa-00843.Vendor Advisory
FAQ
What is CVE-2023-32662?
CVE-2023-32662 is a vulnerability with a CVSS score of 6.7 (MEDIUM). Improper authorization in some Intel Battery Life Diagnostic Tool installation software before version 2.2.1 may allow a privilaged user to potentially enable escalation of privilege via local access.
How severe is CVE-2023-32662?
CVE-2023-32662 has been rated MEDIUM with a CVSS base score of 6.7/10. Review the CVSS metrics above for detailed severity breakdown.
Is there a patch for CVE-2023-32662?
Check the references section above for vendor advisories and patch information. Affected products include: Intel Battery Life Diagnostic Tool.